|
1
|
Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt-mTOR signaling pathway in oral squamous cell carcinoma.
|
Cancer Lett
|
2011
|
0.92
|
|
2
|
Erucylphospho-N,N,N-trimethylpropylammonium (erufosine) is a potential antimyeloma drug devoid of myelotoxicity.
|
Cancer Chemother Pharmacol
|
2010
|
0.84
|
|
3
|
The expression level of the tumor suppressor retinoblastoma protein (Rb) influences the antileukemic efficacy of erucylphospho-N,N,N-trimethylpropylammonium (ErPC3).
|
Cancer Biol Ther
|
2007
|
0.77
|
|
4
|
Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins.
|
J Cancer Res Clin Oncol
|
2012
|
0.76
|